High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice

Clin Oncol (R Coll Radiol). 2016 Sep;28(9):611. doi: 10.1016/j.clon.2016.03.006. Epub 2016 May 4.

Authors

J S Tanguay¹, C Catlow², C Smith¹, J Barber¹, J Staffurth², S Kumar¹, N Palaniappan¹, M Button¹, M D Mason²

Affiliations

¹ Velindre Cancer Centre, Cardiff, UK.
² Cardiff University, Cardiff, UK.

PMID: 27131755
DOI: 10.1016/j.clon.2016.03.006

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Docetaxel
Humans
Male
Neutropenia
Prostatic Neoplasms*
Taxoids*

Substances

Taxoids
Docetaxel